PASADENA Prasinezumab 12 month data

PASADENA Prasinezumab 12 month data
Prof Simon Lewis describes the press release reporting the 12 month data of the PASADENA study evaluating prasinezumab, a novel monoclonal antibody aiming to slow disease progression in patients with early stage Parkinson’s Disease. VIEW ALL VIDEOS The post PASADENA Prasinezumab 12 month data appeared first on Prof. Simon Lewis. ... read more
Source: Prof. Simon LewisPublished on 2020-04-27By JP